Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage

International Journal of Gynecology and Obstetrics

Volumn 105, Issue 3, 2009, Pages 244-247

  Nasr, Ahmed ^a   Shahin, Ahmed Y ^a   Elsamman, Ali M ^a   Zakherah, Mahmoud S ^a   Shaaban, Omar M ^a  

^a ASSIUT UNIVERSITY   (Egypt)

Author keywords

Misoprostol; Oxytocin; Postpartum hemorrhage; Third stage of labor

Indexed keywords

MISOPROSTOL; MISOTAC; OXYTOCIN; PLACEBO; RINGER SOLUTION; SODIUM CHLORIDE; UNCLASSIFIED DRUG; UTEROTONIC AGENT;

ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; FEMALE; FEVER; HEMATOCRIT; HUMAN; LABOR; MAJOR CLINICAL STUDY; NAUSEA; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; SHIVERING; TREATMENT OUTCOME; VOMITING;

EID: 67349148297     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2009.01.018     Document Type: Article

References (24)

1. World Health Organization, World Bank. Maternal health around the world. Poster. World Health Organization and the World Bank; 1997.
2. Kwast B.E., Rochat R.W., and Kidane-Mariam W. Maternal mortality in Addis Ababa, Ethiopia. Stud Fam Plann 17 6 Pt 1 (1986) 288-301
3. Carroli G., Cuesta C., Abalos E., and Gulmezoglu A.M. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol 22 6 (2008) 999-1012
4. Watkinson G., Hopkins A., and Akbar F.A. The therapeutic efficacy of misoprostol in peptic ulcer disease. Postgrad Med J 64 Suppl 1 (1988) 60-77
5. Chong Y.S., Su L.L., and Arulkumaran S. Misoprostol: a quarter century of use, abuse, and creative misuse. Obstet Gynecol Surv 59 2 (2004) 128-140
6. Derman R.J., Kodkany B.S., Goudar S.S., Geller S.E., Naik V.A., Bellad M.B., et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomized controlled trial. Lancet 368 9543 (2006) 1248-1253
7. Gupta B., Jain V., and Aggarwal N. Rectal misoprostol versus oxytocin in the prevention of postpartum hemorrhage - a pilot study. Int J Gynecol Obstet 94 Suppl 2 (2006) S139-S140
8. Walraven G., Blum J., Dampha Y., Sowe M., Morison L., Winikoff B., et al. Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia; a randomised controlled trial. BJOG 112 9 (2005) 1277-1283
9. Chandhiok N., Dhillon B.S., Datey S., Mathur A., and Saxena A.C. Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India. Int J Gynecol Obstet 92 2 (2006) 170-175
10. Hoj L., Cardosa P., Nielsen B.B., Hvidman L., Nielsen J., and Aaby P. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomized double blind clinical trial. BMJ 331 7519 (2005) 723
11. Caliskan E., Meydanli M.M., Dilbaz B., Aykan B., Sonmezer M., and Haneral A. Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial. Am J Obstet Gynecol 187 4 (2002) 1038-1045
12. Prendiville W.J., Elbourne D., and McDonald S. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev 3 (2000) CD000007
13. Vimala N., Mittal S., and Kunar S. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section. Int J Gynecol Obstet 92 2 (2006) 106-110
14. Shojai R., Desbrière R., Dhifallah S., Courbière B., Ortega D., d'Ercole C., et al. Rectal misoprostol for postpartum hemorrhage. [in French]. Gynecol Obstet Fertil 32 9 (2004) 703-707
15. Baruah M., and Cohn G.M. Efficacy of rectal misoprostol as second-line therapy for the treatment of primary postpartum hemorrhage. J Reprod Med 53 3 (2008) 203-206
16. Mousa H.A., and Alfirevic Z. Treatment for primary postpartum hemorrhage. Cochrane Database Syst Rev 1 (2007) CD003249
17. Bamigboye A.A., Merrell D.A., Hofmeyr G.J., and Mitchell R. Randomized comparison of rectal misoprostol with Syntometrine for management of third stage of labor. Acta Obstet Gynecol Scand 77 2 (1998) 178-181
18. Nellore V., Mittal S., and Dadhwal V. Rectal misoprostol vs. 15-methyl prostaglandin F2alpha for the prevention of postpartum hemorrhage. Int J Gynecol Obstet 94 1 (2006) 45-46
19. Tang O.S., Gemzell-Danielsson K., and Ho P.C. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynecol Obstet 99 Suppl 2 (2007) S160-S167
20. Meckstroth K.R., Whitaker A.K., Bertisch S., Goldberg A.B., and Darney P.D. Misoprostol administered by epithelial routes. Obstet Gynecol 108 3 Pt 1 (2006) 582-590
21. Gulmezoglu A.M., Villar J., Ngoc N.T., Piaggio G., Carroli G., Adetoro L., et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 358 9283 (2001) 689-695
22. Baskett T.F., Persad V.L., Clough H.J., and Young D.C. Misoprostol versus oxytocin for the reduction of postpartum blood loss. Int J Gynecol Obstet 97 1 (2007) 2-5
23. Bugalho A., Daniel A., Faúndes A., and Cunha M. Misoprostol for prevention of postpartum hemorrhage. Int J Gynecol Obstet 73 1 (2001) 1-6
24. Hofmeyr G.J., and Gulmezoglu A.M. Misoprostol for the prevention and treatment of postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 22 6 (2008) 1025-1041